labial melanotic macule. Lip macula - Hoogstra Labial melanotic macule. B). Increased

doi: 10.1126/science.1239275 139 DiPatrizioNVPiomelliD

Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing

Consequently, the slow-releasing H 2 S donors, such as GYY4137 and dithiolthione compounds, offer an attractive alternative, providing controlled release and sustained H 2 S bioavailability that more closely mimics endogenous production rates, thereby reducing the risk of bolus effects (Giustarini et al., 2010

Although the anticancer and antibacterial mechanisms of ph-ph + are not fully understood, preliminary studies suggest that they may be related to the inhibition of energy generation in eukaryotic cell mitochondria and bacteria